Physician
Acute Patient Care INC
Acute Patient Care INC was paid $1.82M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.
33Billing provider infoACUTE PATIENT CARE INC
KISSIMMEE, FL 34741
KISSIMMEE, FL 34741
33aNPI1639288731assigned 08/30/2006
33bProvider typeInternal Medicine Physician
28Total paid$1.82M
24GClaims92,776
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Florida
Rank by total paid#26 of 1,247
Median peer was paid$9K
This provider vs. median208×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,309 | $11K | |
| 2019 | 10,044 | $221K | |
| 2020 | 13,684 | $369K | |
| 2021 | 13,182 | $273K | |
| 2022 | 20,464 | $387K | |
| 2023 | 21,163 | $313K | |
| 2024incomplete | 12,930 | $249K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 48% | 26,104 | 16,875 | $874K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 31,413 | 18,614 | $674K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.4% | 9,808 | 8,135 | $172K |
| 99223 | Prolong inpt eval add15 m | 1.5% | 183 | 152 | $28K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 1,230 | 191 | $15K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 245 | 221 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,693 | 1,550 | $10K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 950 | 808 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 430 | 385 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,581 | 1,327 | $5K |
| 99490 | Ccm add 20min | <1% | 160 | 130 | $2K |
| 99220 | <1% | 18 | 14 | $2K |
44 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $1K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 156 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 53 | $958.90 |
| 80061 | Lipid panel | <1% | 233 | $940.02 |
| 80053 | Comprehensive metabolic panel | <1% | 231 | $719.55 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 159 | $610.10 |
| 99307 | <1% | 95 | $449.94 | |
| 99439 | <1% | 43 | $385.17 | |
| 99458 | <1% | 47 | $369.70 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 140 | $352.01 |
| 82607 | <1% | 173 | $350.21 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 150 | $330.01 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 146 | $320.37 |
| 3074F | <1% | 419 | $300.00 | |
| 1090F | <1% | 5,865 | $230.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 618 | $209.92 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 20 | $175.57 |
| 82746 | <1% | 63 | $150.15 | |
| 99457 | <1% | 59 | $117.08 | |
| 86328 | <1% | 42 | $81.15 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 43 | $67.05 |
| 3075F | <1% | 230 | $50.00 | |
| 1100F | <1% | 2,472 | $49.03 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 50 | $36.48 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 29 | $29.79 |
| 82962 | <1% | 46 | $4.96 | |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | <1% | 16 | $4.57 |
| 81002 | <1% | 36 | $2.09 | |
| 2000F | 0% | 735 | $0.00 | |
| 3079F | 0% | 175 | $0.00 | |
| 3008F | 0% | 803 | $0.00 | |
| 1125F | 0% | 401 | $0.00 | |
| 1101F | 0% | 687 | $0.00 | |
| 1126F | 0% | 225 | $0.00 | |
| 3080F | 0% | 93 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 41 | $0.00 |
| 2001F | 0% | 728 | $0.00 | |
| 1111F | 0% | 27 | $0.00 | |
| 3028F | 0% | 488 | $0.00 | |
| 3078F | 0% | 390 | $0.00 | |
| 1159F | 0% | 738 | $0.00 | |
| 1160F | 0% | 742 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 13 | $0.00 |
| 3077F | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAFZAL, AJAZ (PRESIDENT)